ERBB2 and gastric cancer: Diffuse gastric cancer with CDH1 mutation has more aggressive phenotypic characteristics, especially with a higher Ki67 marker index, p53 mutation and Her-2 positive gastric cancer (Muzashvili et al., 2020).